Back to Results
First PageMeta Content
Piperazines / Organochlorides / Atypical antipsychotics / Eli Lilly and Company / Psychopathology / Antipsychotic / Bipolar disorder / Loxapine / Olanzapine / Chemistry / Psychiatry / Organic chemistry


Alexza Pharmaceuticals, Inc. ADASUVE Psychopharmacologic Drugs Advisory Committee Briefing Document
Add to Reading List

Open Document

File Size: 1,52 MB

Share Result on Facebook

Company

Redaction Page 8 Alexza Pharmaceuticals Inc. / Redaction Page 7 Alexza Pharmaceuticals Inc. / Redaction Page 5 Alexza Pharmaceuticals Inc. / Redaction Page 9 Alexza Pharmaceuticals Inc. / Redaction Page 2 Alexza Pharmaceuticals Inc. / Calmness Evaluation Scale AE / Alexza Pharmaceuticals Inc. / Redaction Page 3 Alexza Pharmaceuticals Inc. / Redaction Page 6 Alexza Pharmaceuticals Inc. / Redaction Page 4 Alexza Pharmaceuticals Inc. / EXECUTIVE OVERVIEW Agitation Alexza Pharmaceuticals Inc / /

Currency

pence / /

Facility

Stable Antipsychotic Regimens / Stable Antipsychotic Therapy / /

MedicalCondition

Bronchospasm / COPD / Schizophrenia / I Disorder / Chronic / CNS central nervous system COPD / Psychiatric Disorders / Disorder / physical injuries / Chronic / Stable Antipsychotic Therapy / Bipolar Disorder / Asthma / /

Organization

Administration of Repeat Doses of ADASUVE / Food and Drug Administration / Loxapine Pharmacokinetic Parameters Following Administration of ADASUVE / United States VAS / FDA / Administration of ADASUVE / Administration of Dose / /

Product

Olanzapine / Loxapine / Short-Acting Beta-Agonist Bronchodilator / IM injection / Additional Study Medication / IM injections / Abilify / Study Medication / Albuterol / Zyprexa / /

PublishedMedium

24 Hours / /

Technology

Pharmacokinetics / Pharmacodynamics / 2 Protocol / CGI / /

SocialTag